Pediatric low‑grade gliomas (pLGGs) have distinct biology and treatment strategies compared to adult gliomas. These Chinese consensus guidelines ...

Pediatric low-grade gliomas (pLGGs) exhibit distinct biological and clinical characteristics compared to adult gliomas, and their treatment strategies differ substantially from those used in adults.

March 4 (Reuters) - (Health Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us? Forward this newsletter to them. They can also subscribe here.) Adding a ...

A project at Keck Medicine of USC has developed a laser-based treatment that may dramatically improve survival for patients with brain cancer. Published in Nature Communications the findings offer ...

LOS ANGELES — High-grade astrocytoma, which includes glioblastoma, is a fast-growing, aggressive brain cancer that often returns after the tumor is removed, making it difficult to treat. Patients with ...

During a live event, Jan Drappatz, MD, surveyed participants on the rationale for their choice of treatment for a 39-year-old patient with grade 2 astrocytoma. Grade 2 gliomas occur in younger adults ...

Huntsman Cancer Institute at the University of Utah (the U) participated in a clinical trial that found that a new combination treatment plan helped people with recurring grade 3 astrocytoma, an ...

Huntsman Cancer Institute at the University of Utah (the U) participated in a clinical trial that found that a new combination treatment plan helped people with recurring grade 3 astrocytoma, an ...

Huntsman Cancer Institute at the University of Utah (the U) participated in a clinical trial that found that a new combination treatment plan helped people with recurring grade 3 astrocytoma, an ...

The STELLAR Phase 3 clinical trial found that a new treatment approach helped people with a tough-to-treat brain cancer, called grade 3 astrocytoma, live longer. The new treatment is a major step ...

Vorasidenib significantly reduced tumor growth rates in IDH1/2-mutant grade 2 glioma, improving PFS and TTNI compared to placebo. Linear, biexponential, and VDE modeling approaches consistently showed ...